New treatment for IgA nephropathy: enteric budesonide targeted to the ileocecal region ameliorates proteinuria.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Volumn 26, Issue 10, 2011, Pages 3237-3242

  Smerud, Hilde Kloster ^a   Bárány, Peter ^b   Lindström, Karin ^b   Fernström, Anders ^b   Sandell, Anna ^b   Påhlsson, Peter ^b   Fellström, Bengt ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BUDESONIDE;

ADULT; AGED; ALBUMINURIA; ARTICLE; ENTERIC COATED TABLET; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; ILEOCECAL VALVE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FUNCTION TEST; MALE; MIDDLE AGED; PILOT STUDY; PROGNOSIS;

ADULT; AGED; ALBUMINURIA; ANTI-INFLAMMATORY AGENTS; BUDESONIDE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HUMANS; ILEOCECAL VALVE; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PILOT PROJECTS; PROGNOSIS; TABLETS, ENTERIC-COATED; YOUNG ADULT;

EID: 84859747590     PISSN: None     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr052     Document Type: Article

References (0)